NICE proposes to recommend another treatment for people with multiple myeloma

[:content [\2 \1 \space \M \a \r \c \h \space \2 \0 \1 \4 \space \- \  \I \n \space \n \e \w \  \d \r \a \f \t \space \g \u \i \d \a \n \c \e \  \p \u \b \l \i \s \h \e \d \space \t \o \d \a \y \space \( \2 \1 \space \M \a \r \c \h \) \, \space \N \I \C \E \space \h \a \s \space \r \e \c \o \m \m \e \n \d \e \d \space \b \o \r \t \e \z \o \m \i \b \space \( \V \e \l \c \a \d \e \) \space \a \s \space \a \space \t \r \e \a \t \m \e \n \t \space \f \o \r \space \s \o \m \e \space \p \a \t \i \e \n \t \s " ..."]]
Read more →

Call for submissions: Stage 3 of the PBAC post-market review of products used in the management of patients with diabetes mellitus

[:content [\T \h \e \space \c \a \l \l \space \f \o \r \space \p \u \b \l \i \c \space \s \u \b \m \i \s \s \i \o \n \s \space \i \s \space \n \o \w \space \o \p \e \n \space \f \o \r \space \S \t \a \g \e \space \3 \space \o \f \space \t \h \e \space \D \i \a \b \e \t \e \s \space \R \e \v \i \e \w \space \f \o \r \space \a \space \p \e \r \i \o \d \space \o \f \space \s \i \x " ..."]]
Read more →

CDR recommends self-injectable subcutaneous formulation of first non anti-TNF biological treatment available in both intravenous and subcutaneous formulations to be reimbursed for Canadians with moderately to severely active RA

[:content [\B \r \i \s \t \o \l \- \M \y \e \r \s \space \S \q \u \i \b \b \space \C \a \n \a \d \a \space \h \a \s \space \a \n \n \o \u \n \c \e \d \space \t \h \a \t \space \t \h \e \space \C \o \m \m \o \n \space \D \r \u \g \space \R \e \v \i \e \w \space \h \a \s \space \r \e \c \o \m \m \e \n \d \e \d \space \t \h \a \t \space \t \h \e \space \s \e \l \f \- \i \n \j \e \c \t \a \b \l \e \space \s \u \b \c \u \t \a \n \e \o \u \s \space \f \o \r \m \u \l \a \t \i \o \n \space \o \f \space \t \h \e \space \r \h \e \u \m \a \t \o \i \d " ..."]]
Read more →

Response to Daily Mail article on credit card usage

[:content [\1 \1 \space \J \a \n \u \a \r \y \space \2 \0 \1 \4 \space \- \  \A \c \c \u \s \a \t \i \o \n \s \space \t \h \a \t \space \o \f \f \i \c \i \a \l \s \space \a \t \space \N \I \C \E \space \h \a \v \e \space \u \s \e \d \space \c \r \e \d \i \t \space \c \a \r \d \s \space \o \n \space \l \u \x \u \r \y \space \h \o \t \e \l \s \space \a \n \d \space \c \h \a \m \p \a \g \n \e \space \b \a \r \s \space \a \r \e \space \r \e \p \o \r \t \e \d " ..."]]
Read more →

2015 CADTH Symposium - request to attend

CADTH is pleased to announce that it is now accepting requests to register for the 2015 CADTH Symposium being held at the TCU Place, ...

Read more →

New treatment for cancer approved for PBS listing

Pancreatic cancer drug Abraxane will be listed on the PBS from November 1.

The Australian Government has committed over $92 million ...

Read more →

Eylea (aflibercept) offers new hope for patients suffering from wet age-related macular degeneration

[:content [\1 \2 \space \N \o \v \e \m \b \e \r \space \2 \0 \1 \3 \space \- \  \B \a \y \e \r \space \I \n \c \. \space \a \n \n \o \u \n \c \e \d \space \t \h \a \t \space \i \t \space \h \a \s \space \r \e \c \e \i \v \e \d \space \a \p \p \r \o \v \a \l \space \f \r \o \m \space \H \e \a \l \t \h \space \C \a \n \a \d \a \space \f \o \r \space \E \y \l \e \a \space \( \a \f \l \i \b \e \r \c \e \p \t \, \space \s \o \l \u \t \i \o \n \space \f \o \r \space \i \n \t \r \a \v \i \t \r \e \a \l " ..."]]
Read more →

Schedule of Pharmaceutical Benefits - 1 November 2014 update

The 1 November 2014 issue of the Schedule of Pharmaceutical Benefits is now available and in effect. The new issue contains ...

Read more →

NICE recommends NHS funding for new cancer treatment

[:content [\2 \6 \space \F \e \b \r \u \a \r \y \space \2 \0 \1 \4 \space \- \  \S \o \m \e \space \p \a \t \i \e \n \t \s \space \w \i \t \h \space \a \n \space \a \g \g \r \e \s \s \i \v \e \space \t \y \p \e \space \o \f \space \n \o \n \- \H \o \d \g \k \i \n \' \s \space \l \y \m \p \h \o \m \a \space \- \space \a \space \c \a \n \c \e \r \space \t \h \a \t \space \d \e \v \e \l \o \p \s \space \i \n \space \t \h \e \space \b \o \d \y \' \s " ..."]]
Read more →

New NICE website

NICE has updated its website; the URLs for all Appraisal Consultation Documents and Final Appraisal Determinations have changed.  The links in ...

Read more →

Speeding up access to innovative drugs, devices and diagnostics

Sir Hugh Taylor writes on the work of the Accelerated Access Review to improve access to innovative healthcare for NHS ...

Read more →

Entyvio first biologic to get NICE backing for UC

Takeda’s Entyvio (vedolizumab) has become the first biologic therapy to get a provisional yes from the National Institute for Health ...

Read more →

Post-market review of PBS medicines used to treat asthma in children

The PBAC minutes from the July 2014 meeting on the post-market review of PBS medicines used to treat asthma in ...

Read more →

Proposal to fund preservative free Minims prednisolone sodium phosphate 0.5% eye drops

PHARMAC is seeking feedback on a proposal to fund preservative free prednisolone sodium phosphate 0.5% eye drops, resulting from a ...

Read more →

UK government reaches deal with GSK for MenB jab

UK babies will be the first worldwide to be routinely vaccinated against meningitis B, after the UK government finally reached ...

Read more →